Source: FinanzNachrichten

AiCuris: AiCuris Anti-Infective Cures AG: AiCuris' Innovation Accelerator AiCubator Calls for Innovative Proposals to Propel Anti-Infective Drug Development in The Third Round

The AiCubator program was launched to provide first-hand support to fuel early research projects of young start-ups and academic teams that have the potential to become the next generation of resis...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Larry Edwards's photo - President & CEO of AiCuris

President & CEO

Larry Edwards

CEO Approval Rating

82/100

Read more